Sanaby Health Acquisition Corp. I Announces Liquidation

Rhea-AI Summary

Sanaby Health Acquisition Corp. I (SANB) announced it will dissolve and liquidate after failing to complete a business combination by the deadline of October 19, 2022. All outstanding shares of Class A common stock will be redeemed at approximately $10.22 per share. The company cited current market dynamics and economic uncertainty as reasons for the decision, emphasizing a commitment to returning capital to shareholders. The liquidation process will include the necessary actions to disburse funds from the trust account, with liquidations expected to be completed within ten business days following the announced date.

Positive

• None.

Negative

• Inability to complete a business combination within the required timeframe.
• Dissolution of the company indicates failure to identify a viable acquisition target.
• Market dynamics and economic uncertainty hindered potential growth opportunities.
• Warrants will expire worthless, representing a loss for warrant holders.

PALO ALTO, Calif.--(BUSINESS WIRE)-- Sanaby Health Acquisition Corp. I (NASDAQ: SANB) (the “Company”) announced today that due to its inability to consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation, as amended (the “Amended Charter”) the Company intends to dissolve and liquidate in accordance with the provisions of its Amended Charter, effective as of the close of business on October 19, 2022, and will redeem all of the outstanding shares of Class A common stock that were included in the units issued in its initial public offering (the “Public Shares”), at a per-share redemption price of approximately $10.22 (without giving effect to any interest that may be withdrawn to pay for taxes and dissolution expenses).

As of the close of business on October 19, 2022, the Public Shares will be deemed cancelled and will represent only the right to receive the redemption amount.

“Throughout this journey, we have maintained a disciplined approach that focused on identifying the best possible acquisition candidate to deliver long-term value to our shareholders,” said Sandra Shpilberg, Chief Executive Officer of Sanaby Health Acquisition Corp. I. “We met with many innovative companies over the last 12 months; however, current market dynamics and lingering economic uncertainty convinced us that the best way to deliver on our promise to shareholders was to return the capital held in trust.”

In order to provide for the disbursement of funds from the trust account, the Company has instructed the trustee of the trust account to take all necessary actions to liquidate the securities held in the trust account. The proceeds of the trust account will be held in a non-interest bearing account while awaiting disbursement to the holders of the Public Shares. Record holders will receive their pro rata portion of the proceeds of the trust account by delivering their Public Shares to Continental Stock Transfer & Trust Company, the Company’s transfer agent. Beneficial owners of Public Shares held in “street name,” however, will not need to take any action in order to receive the redemption amount. The redemption of the Public Shares is expected to be completed within ten business days after October 19, 2022.

The Company’s sponsor has agreed to waive its redemption rights with respect to its outstanding Class B common stock issued prior to the Company’s initial public offering.

There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless.

Forward-Looking Statements

This press release may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are based on the beliefs and reasonable assumptions of management, and actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements after the date of this release, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221017005994/en/

Sanaby Health Acquisition Corp. I

Sandra Shpilberg, CEO

(415) 580-1810

info@sanaby.com

www.sanaby.com

Source: Sanaby Health Acquisition Corp. I

FAQ

What is the planned liquidation date for Sanaby Health Acquisition Corp. I?

The planned liquidation date for Sanaby Health Acquisition Corp. I is October 19, 2022.

What will be the redemption price for SANB shareholders?

Shareholders will redeem their shares at approximately $10.22 per share.

Why is Sanaby Health Acquisition Corp. I dissolving?

The company is dissolving due to its inability to complete a business combination amid current market conditions and economic uncertainty.

What happens to the Class B common stock during the liquidation?

The sponsor of the company has agreed to waive its redemption rights concerning the Class B common stock.

How will the liquidation process affect the warrants held by investors?

There will be no redemption rights or liquidating distributions for the company's warrants, and they will expire worthless.